NRGN and Alzheimer disease: Increased Ng expression in the brain regions affected by AD (i.e. hippocampus and parietal and temporal cortex) could explain the increased Ng levels in the CSF of patients with AD, but not FTLD, as these regions suffer from greater synapse loss than the regions predominantly affected by FTLD [49].